Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Birkeland, SA"'
Publikováno v:
Tissue Antigens. 6:28-36
Between 1965 and 1973, 30 malignant tumours were found in patients transplanted in Scandinavia. Of these tumours, 24 were found in the 1,254 patients transplanted in Scandinavia as part of the Scandia Tranplant Programme between 1969 and 1972. Using
Autor:
Birkeland Sa, Stephen Hamilton-Dutoit
Publikováno v:
Birkeland, S A & Hamilton-Dutoit, S J 2003, ' Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? ' Transplantation, vol. 76, no. 6, pp. 984-8 . https://doi.org/10.1097/01.TP.0000085602.22498.CF
Background An association between posttransplant lymphoproliferative disorder (PTLD) and cyclosporine A (CsA) and OKT3 has often been postulated on the basis of retrospective studies, although a randomized study with PTLD as the endpoint will probabl
Publikováno v:
Transplantation. 67:1209-1214
Background: A widely held view is that any increase in the potency of an immunosuppressive agent will lead to an increase in infection and malignancy, such as life-threatening Epstein-Barr virus (EBV) induced posttransplant lymphoproliferative disord
Autor:
Stephen Hamilton-Dutoit, Birkeland Sa, Bjarne Kuno Møller, Hans Kerzel Andersen, Klaus Bendtzen
Publikováno v:
Transplantation. 67:876-881
Background. Posttransplant lymphoproliferative disorder (PTLD) is a life-threatening complication of transplantation, which comprises a morphologically and clinically heterogeneous spectrum of B-lymphocyte diseases. Risk factors include primary or re
Autor:
Birkeland Sa
Publikováno v:
Transplant International. 11:397-400
Organ transplantation is now a routine treatment for a number of chronic kidney, heart, lung, and liver diseases. We have accumulated much knowledge about these treatments in the respective disciplines, and it seems appropriate to reflect on some gen
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 30:227-230
The development of IgG and IgM anti-OKT3 antibodies the first 90 days after start of OKT3 treatment for acute cellular rejection was determined by ELISA in 25 consecutive renal transplant patients. The ELISA positive sera were then tested for neutral
Autor:
Jorgen Ladefoged, I. Blohmé, Michael Friedberg, Eystein Glattre, Hans H. Storm, Lotti Barlow, Birkeland Sa, Niels V. Holm, Tore Lindholm, Lars Frödin, Bjorn Forsberg, Eero Pukkala, Stein Halvorsen, L. U. Lamm, Göran Lundgren, Hans E. Jorgensen, Ole Fjeldborg, Bjorn Eklund, Amt Jakobsen
Publikováno v:
International Journal of Cancer. 60:183-189
The theory that cancer may arise under conditions of reduced immune capacity is supported by observations of humans with immune deficiencies such as occur following organ transplants. However, no study on humans has been done in which the reference p
Publikováno v:
Transplant Immunology. 2:308-312
A total of 1303 fine needle aspiration biopsies (FNABs) were performed in all 105 kidney transplanted patients at our institution during 1990–1992: 838 were in patients who never had an acute cellular rejection (ACR), and 465 were in patients who h
Autor:
Guido Pozza, Nils Rohr, V. di Carlo, Finn Lund Henriksen, Carlo Socci, Henning Beck-Nielsen, Birkeland Sa, Thomas B. Nielsen, Antonio Secchi, Karl-Egon Larsen, Knud Bonnet Yderstræde
Publikováno v:
University of Southern Denmark
INSULIN independency in insulin-dependent diabetes mellitus (IDDM) patients after allogeneic islet transplantation has been achieved on several occasions. The International Islet Transplant Registry reports 8 cases, in which insulin could be disconti
Autor:
Birkeland SA, BeckNielsen H, Rohr N, Socci C, Christensen J, Dieperink H, Jorgensen KA, Knudsen DU, Larsen KE, Sjolie AK, Tofte H, Yderstraede K, Bertuzzi F, Birkeland P, DiCarlo V, Pozza G., SECCHI , ANTONIO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::f593cd4010349671e8a9bc3bfe9600c8